HKDC1 Promotes Liver Cancer Stemness Under Hypoxia via Stabilizing β-Catenin
L. Fan, C. Tian, W. Yang, X. Liu, Y. Dhungana, H. Tan, E. S. Glazer, J. Yu, J. Peng, L. Ma, M. Ni, L. Zhu
This study identifies HKDC1 as a prometastatic enzyme in liver cancer that stabilizes β-catenin under hypoxia, enhancing cancer stemness.
bioRxiv · Feb 27, 2024Cancer Biology